How to Enhance Translatability of Myeloid-Targeted Therapies in Preclinical Models
Time: 9:30 am
day: Conference Day Two
Details:
- Outlining BRGSF-HIS mice: Immunodeficient mice displaying functional human lymphoid and myeloid compartments, without GvHD and side effects
- Examining myeloid cells functionality and assessing immune modulation induced by biologics in BRGSF-HIS model
- Showcase of assessment of immune targeting agents in immune checkpoint humanized model
